Neoplasms: all 9,610 studies
Page 84 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- The Impact of Chemotherapy on Memory Function and the Development of Traumatic Symptoms in Children With CancerStatus unknownNCT01108952
- Pharmacogenetic Response to Chemotherapy Induction for ORL CancersCompletedNCT01104714
- Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)CompletedNCT01104077
- A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid MalignanciesCompletedNCT01103791Phase 1
- Evaluation of Multidisciplinary Palliative Care on Terminal Cancer Patients in TaiwanStatus unknownNCT01103700
- A Study of MEDI-575 in Patients With Advanced Solid MalignanciesCompletedNCT01102400Phase 1
- Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
- Smoking Cessation Treatment for Head & Neck Cancer PatientsActive, not recruitingNCT01098955Early Phase 1
- Safety and Efficacy of LCL161 in Patients With Solid TumorsCompletedNCT01098838Phase 1
- A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate CancerCompletedNCT01095848Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid TumorsCompletedNCT01095302Phase 1
- Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)Status unknownNCT01095198Phase 2/3
- Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesCompletedNCT01094860Phase 1
- The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and ProgressStatus unknownNCT01092247Not applicable
- Study of NMS-1116354 in Advanced/Metastatic Solid TumorsTerminatedNCT01092052Phase 1
- Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid NeoplasiaCompletedNCT01089335
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
- Mortality Due to Malignancy in Patients With Idiopathic Venous ThromboembolismTerminatedNCT01088334
- Lapatinib With Sirolimus or MetforminCompletedNCT01087983Phase 1
- Effect of Cabazitaxel on the QTc Interval in Cancer PatientsCompletedNCT01087021Phase 1
- Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT01086735Phase 1/2
- Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation CourseCompletedNCT01086683Phase 2/3
- Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid TumorsTerminatedNCT01081808Phase 1
- Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell TransplantationCompletedNCT01081405Not applicable
- A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological MalignanciesTerminatedNCT01080664Phase 1
- Everolimus and Capecitabine in Patients With Advanced MalignancyStatus unknownNCT01079702Phase 1/2
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantTerminatedNCT01077440
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Temsirolimus and Pazopanib in Patients With Advanced Solid TumorsCompletedNCT01072890Phase 1
- A Dose-escalation Study in Subjects With Advanced MalignanciesCompletedNCT01072266Phase 1
- A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007)CompletedNCT01071018Phase 1
- A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy RegimenWithdrawnNCT01070290Phase 2
- Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
- Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and NeckCompletedNCT01067196
- AZD2171 and Temsirolimus in Patients With Advanced Gynecological MalignanciesCompletedNCT01065662Phase 1
- Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide PolymorphismsActive, not recruitingNCT01064466Phase 2/3
- A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid TumorCompletedNCT01063946Phase 1
- A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid TumorsCompletedNCT01063816Phase 1
- Selumetinib and Cixutumumab in Treating Patients With Advanced Solid MalignanciesCompletedNCT01061749Phase 1
- A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid TumoursCompletedNCT01058538Phase 1/2
- HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CINStatus unknownNCT01058460Not applicable
- Oligogenic Determinism of Colorectal CancerCompletedNCT01057953Not applicable
- Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic NeoplasmsWithdrawnNCT01057355Phase 1
- HAI Abraxane With Gemcitabine and BevacizumabCompletedNCT01057264Phase 1
- Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid TumorsCompletedNCT01056029Phase 1
- Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid TumorsCompletedNCT01055795Phase 1
- Docetaxel and Sirolimus in Patients With Advanced MalignanciesCompletedNCT01054313Phase 1
- Anidulafungin in Patients With Hematologic MalignanciesTerminatedNCT01053884Phase 2
- A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and LymphomasCompletedNCT01051635Phase 1
- Evaluation of Thymidine Kinase Activity in the Serum of Patients With Solid TumorsStatus unknownNCT01050413
- Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid TumorsCompletedNCT01049893Phase 1
- Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsCompletedNCT01049841Phase 1
- A Study of MORAb-003 in Patients With Solid TumorCompletedNCT01049061Phase 1
- Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced CancerCompletedNCT01048008Phase 1
- The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 DiabetesActive, not recruitingNCT01047735Not applicable
- Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateCompletedNCT01046487Phase 1
- Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology PatientsStatus unknownNCT01046227
- Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related FatigueCompletedNCT01043913Phase 2
- A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerCompletedNCT01039948Phase 1/2
- A Study to Test Lung Function After Radiation TherapyCompletedNCT01039649
- Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum TherapyCompletedNCT01039155Phase 1
- Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksStatus unknownNCT01037049Phase 2
- Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic MalignanciesCompletedNCT01034475Phase 1
- Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the BreastCompletedNCT01031238
- ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid TumorsWithdrawnNCT01031212Phase 1
- Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging SystemCompletedNCT01030497
- Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid TumorsCompletedNCT01030055Phase 1
- Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening ProgramCompletedNCT01029990Early Phase 1
- Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 MutationsCompletedNCT01024413Phase 3
- Analysis of Pharmacodynamic Changes With AUY922A, an HSP90 InhibitorStatus unknownNCT01024283
- Hydroxychloroquine + Vorinostat in Advanced Solid TumorsCompletedNCT01023737Phase 1
- Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal CancersCompletedNCT01023529
- Effects of 3 Day Preoperative Immunonutrition in Well-nourished Patients With Gastrointestinal (GI) Cancer Undergoing SurgeryTerminatedNCT01023412Not applicable
- A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) InfectionCompletedNCT01022346Phase 2
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid TumorsCompletedNCT01021150Phase 1
- A First in Man Study of MABp1 in Patients With Advanced CancersCompletedNCT01021072Phase 1
- Study of Ixabepilone (BMS-247550) in Patients With Solid TumorsCompletedNCT01018966Phase 1
- Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in JapanCompletedNCT01018745Phase 1
- Effect of Food and Antacid on BIIB021 With Advanced Solid TumorsCompletedNCT01017198Phase 1
- Study of NMS-1116354 in Solid TumorsTerminatedNCT01016327Phase 1
- Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesCompletedNCT01015222Phase 1
- Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisCompletedNCT01014598Phase 1
- Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid TumorsCompletedNCT01014429Phase 1
- A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid MalignanciesTerminatedNCT01013818Phase 1
- Clinical Study of OncoSorb® in Patients With Advanced Cancer EntitiesTerminatedNCT01013168Phase 1/2
- EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid TumorsCompletedNCT01012102Phase 1
- Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT01009593Phase 3
- Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging SystemCompletedNCT01008930Not applicable
- Motivational Interviewing for Physical ActivityActive, not recruitingNCT01008787Not applicable
- Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic FunctionCompletedNCT01007968Phase 1
- A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesCompletedNCT01004224Phase 1
- Study Evaluating SKI-606 in Subject With Solid TumorsCompletedNCT01001936Phase 1
- Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy SimulatorTerminatedNCT00999960Not applicable
- A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid TumorsCompletedNCT00999401Phase 1
- 10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesCompletedNCT00997945Phase 1
- Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal FunctionCompletedNCT00997399Phase 1
- Study of PKI-179 Administered Orally to Subjects With Solid TumorsWithdrawnNCT00997360Phase 1
- A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor MalignanciesCompletedNCT00996515Phase 1
- Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid TumorsTerminatedNCT00996255Phase 1
- S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersCompletedNCT00996047